This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Regeneron Pharmaceuticals, Inc., Regenxbio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Inventor Li Zhi
Introduction
Li Zhi is an accomplished inventor based in Tarrytown, NY (US). He holds a patent that showcases his expertise in the field of biotechnology. His work primarily focuses on improving methods for analyzing adeno-associated virus (AAV) components, which is crucial for advancements in gene therapy.
Latest Patents
Li Zhi's notable patent is titled "Liquid chromatography assay for determining AAV capsid ratio." This patent describes methods for determining the relative abundance of intact AAV capsid components in a sample of recombinant AAV particles. The methods include a system regeneration process that minimizes or eliminates the presence of ghost peaks, thereby maximizing analytical accuracy and ensuring product quality and consistency. He has 1 patent to his name.
Career Highlights
Throughout his career, Li Zhi has made significant contributions to the field of biotechnology. He has worked with prominent companies such as Regeneron Pharmaceuticals, Inc. and Regenxbio Inc. His experience in these organizations has allowed him to develop innovative solutions that enhance the understanding and application of AAV in therapeutic contexts.
Collaborations
Li Zhi has collaborated with several professionals in his field, including Jonathan Wert and Dingjiang Liu. These collaborations have further enriched his research and development efforts, leading to advancements in the methodologies he has patented.
Conclusion
Li Zhi's contributions to the field of biotechnology, particularly through his patent on AAV analysis, highlight his role as an innovative inventor. His work continues to influence the landscape of gene therapy and related research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
